It was previously reported on May 3 that the Data Package may not be sufficient. Subjectively, that could result in an early dismissal from the FDA, a voluntary delay from […]

It is difficult to find information on this directly from Truist Securities, we will post links as we come across them. PR from ALLO: https://www.biospace.com/article/releases/allogene-therapeutics-announces-participation-in-seven-upcoming-investor-conferences/

This priority review is coming after an Advisory Committee voted 6-4 against it. However, the FDA does what they want after taking the Ad Coms suggestions into account. If they […]

This event is in Boston, and apparently draws a few people beyond the Institutional Investors. Companies presenting include: TCRR, TCBP, CRBU, INAB, INKT, TIL Link to PR: https://www.freemindconsultants.com/2022/05/02/kisaco-octs-2022/ There is […]

Freeport shut down early June due to an explosion. The lack of export ability caused domestic nat gas prices to fall, and international nat gas prices to rise. Again, on […]

AXSM is one of the more volatile tickers in this sector, and as such is likely to experience a strong runup period. Also, this is the 2nd attempt, with the […]

This event is in Boston, and apparently draws a few people beyond the Institutional Investors. Companies presenting include: TCRR, TCBP, CRBU, INAB, INKT, TIL Link to PR: https://www.freemindconsultants.com/2022/05/02/kisaco-octs-2022/ There is […]

This event goes until the 3rd, we are having trouble finding the complete list of companies presenting, but we have an inquiry in to the Non-Profit and hope to have […]

PDUFA PR from HZNP: https://ir.horizontherapeutics.com/news-releases/news-release-details/horizon-therapeutics-plc-announces-fda-has-granted-priority-0

This meeting is a long one, going all the way through the 14th.  Sponsers of the event are almost all larger companies, and include: ASH, CE, EVKIF, AZN, COIHF, and […]

PR for PDUFA Info: https://www.businesswire.com/news/home/20220404005293/en/Alnylam-Announces-3-Month-Extension-of-Review-Period-for-New-Drug-Application-for-Vutrisiran

This event is mostly for larger companies, however there are two that stand out as potential runup or event plays, due to their higher volatility and smaller cap.  The two that stand out are DBVT and ADMA.  Both are highly volatile, and both have the social media support that could amp up a "rumor" period […]

The FDA postponed this decision by 3 months so that they could review data that was submitted late by INCY.  Subjectively, INCY had the option of pulling the plug on the PDUFA decision if they thought they needed to collect new data.  In this case, they determined that if they submitted data late, it would […]

The Share Lockup Expiration Date can lead to all types of price movement. It could be completely inconsequential, or it could rocket the price, or it could tank it. It really all comes down to what the market expects the shareholders who can now sell to do, and what they end up doing. If the […]

The Share Lockup Expiration Date can lead to all types of price movement. It could be completely inconsequential, or it could rocket the price, or it could tank it. It really all comes down to what the market expects the shareholders who can now sell to do, and what they end up doing. If the […]

Oddly enough, there are so many Oppenheimer Events that this one is not as easy to find.  However, below is the PR put out by INAB which declared this event and two others as July Presentations. For a Small Cap ticker like INAB (at the moment, without the Oppenheimer schedule, INAB is the only one […]

From their website: The Gordon Research Seminar on Mitochondria and Chloroplasts is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas. The seminar will select attendees from the submitted abstracts to present their latest work in front […]

This is a big 2 day event for many Medical and Recreational Marijuana companies to present their products, and make presentations about potential future products, partnerships, new directions in R&D, etc.  At the bottom is a link to the Map of where all the companies Booths are.  From our research, the following publicly traded companies […]

We are brand new to this event, and judging from the title of the event, it is probably a heavy event with tons of information for the medically inclined.  However, it is a 3 day event, and has a few companies presenting or sponsoring it who could experience a runup or event trade based on […]

This is a meeting to consider and vote on previously disclosed arrangement between the company and the Republic of Kyrgyz.  More information about this will be posted when we find it.  The stock price leading up to this event has been very negative, but much of that can be attributed to the falling price of […]

The Share Lockup Expiration Date can lead to all types of price movement. It could be completely inconsequential, or it could rocket the price, or it could tank it. It really all comes down to what the market expects the shareholders who can now sell to do, and what they end up doing. If the […]

This event goes until the 28th. It is being publicized by PR from INAB, and we are looking for a schedule so that we can include other companies involved. Link to Event PR from INAB: https://www.biospace.com/article/releases/in8bio-to-present-at-july-investor-and-scientific-conferences/?s=73

Companies involved are almost all larger companies who aren't likely to see a lot of volatility from the event, but any of the smaller ones are worth looking at!  Companies presenting: Sanofi, Merck, Pfizer, AZN, CTLT, VIR, DYAI, Event Website: https://web.cvent.com/event/4fd12abb-0906-4ab1-9817-1a59d3b4aaac/websitePage:89064aa3-15b8-4a75-ba9b-b6495cb18b9d

The Share Lockup Expiration Date can lead to all types of price movement. It could be completely inconsequential, or it could rocket the price, or it could tank it. It really all comes down to what the market expects the shareholders who can now sell to do, and what they end up doing. If the […]

This Fed Meeting is widely expected to culminate in either a .25% or .5% rise in interest rates. Typically, going into the meeting, traders are extra jittery, and volatility tends to increase. The debate going into this one will be how much the interest rate rise will be, and the potential effects. Often, traders hedge […]

The event website makes sure to mention that there will be vendors there, but does not offer a list of who they are. So we are limited to the companies that have already produced PR about it.  We will update it if we can find a list of companies. Event Website: https://www.tscalliance.org/2022-world-tsc-conference/

PR to PDUFA Information: https://investors.arcutis.com/news-releases/news-release-details/fda-accepts-arcutis-biotherapeutics-new-drug-application

BLCT has this special shareholder meeting scheduled to approve (or not) a merger.  The valuation of a company can shift wildly during the runup and the period after the event, in these cases.  A trader would want to have the technicals set up on their Think or Swim and keep an eye on the 1 […]

This event is not a small event.  It goes from July 31-Aug 4 and has a TON of companies with booths and presentations. There are some huge companies, whose presentations are unlikely to be anything to write home about.  But there are also numerous small cap companies that could benefit from both their booth presentation […]